|
Delayed
Sao Paulo
09:51:25 18/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 86.64 BRL | -85.05% |
|
+1.69% | +10.74% |
| 12/08 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 11/08 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.32% | +0.54% | +6.51% | +23.63% | +13.67% | +75.00% | +123.55% | +354.92% | +1,431.16% | 1,05500Cr | |
| +3.34% | +4.30% | +8.90% | +18.36% | +30.93% | +53.74% | +57.09% | +52.92% | +124.45% | 63TCr | |
| +3.16% | +3.12% | +1.79% | +23.16% | +12.87% | +24.85% | +71.78% | +119.89% | +286.26% | 44TCr | |
| +1.35% | -2.17% | +8.80% | +12.19% | +9.96% | +40.98% | +41.50% | -3.13% | +48.27% | 35TCr | |
| +1.75% | -0.24% | +2.00% | +7.13% | +14.56% | +25.28% | +40.46% | +44.74% | +60.05% | 29TCr | |
| +2.13% | -0.32% | -4.64% | -13.89% | -14.39% | +0.58% | +10.77% | +35.20% | +133.97% | 24TCr | |
| +1.64% | +2.91% | +17.07% | +31.43% | +30.26% | +45.70% | +62.84% | +87.95% | +143.97% | 23TCr | |
| +1.35% | -3.53% | -9.65% | +3.62% | -8.89% | -14.72% | -52.63% | -11.46% | +91.50% | 20TCr | |
| +3.05% | +5.52% | +7.54% | +10.48% | +16.72% | +21.42% | +88.80% | +99.08% | +77.76% | 17TCr | |
| +1.58% | +2.52% | +10.26% | +7.74% | +9.60% | +8.86% | -25.56% | -44.66% | -22.45% | 15TCr | |
| +2.40% | +4.15% | +10.12% | +15.60% | +22.82% | +37.48% | +6.75% | -2.47% | +12.90% | 13TCr | |
| +2.48% | -0.17% | +10.04% | +21.11% | +16.63% | +35.62% | +53.34% | +171.48% | +433.56% | 13TCr | |
| +1.32% | +3.01% | +0.99% | +4.48% | -6.10% | -9.24% | -20.74% | -13.36% | +10.69% | 11TCr | |
| +1.97% | -0.42% | +0.32% | +0.61% | +3.48% | +31.20% | +39.96% | -1.01% | -9.80% | 10TCr | |
| -0.25% | -3.73% | -6.53% | -13.74% | -16.94% | +9.67% | +60.31% | +68.27% | +491.11% | 7.09TCr | |
| +3.43% | +2.15% | +4.05% | +8.05% | +17.93% | +29.33% | +28.45% | +56.18% | +21.58% | 5.52TCr | |
| +1.75% | -0.43% | +3.02% | +28.84% | +31.69% | +76.15% | -3.14% | +1.72% | -49.65% | 5.45TCr | |
| -0.95% | -3.34% | -1.54% | -3.00% | -12.09% | -17.40% | +29.09% | -4.35% | +214.56% | 5.17TCr | |
| +0.86% | +1.17% | +19.05% | +8.45% | +18.25% | +104.35% | +286.04% | +290.94% | -30.43% | 4.25TCr | |
| Average | +1.93% | -1.44% | +4.64% | +10.22% | +10.05% | +30.46% | +47.30% | +68.57% | +182.60% | 23.74TCr | |
| Weighted average by Cap. | +2.51% | -1.74% | +5.34% | +14.90% | +13.27% | +39.94% | +60.12% | +121.91% | +431.05% |
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
- Sector Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
